Amazon getting into pharma business still remains a question: JPMorgan health-care analyst

Lisa Gill, JPMorgan health-care analyst, discusses the potential deal between CVS and Aetna and the potential risk of Amazon getting into the pharmaceutical business.

from Mergers and Acquisitions http://ift.tt/2gP1fVm